시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
멀티플렉스 어세이 시장 규모, 점유율, 성장 분석 : 제품 유형별, 유형별, 기술별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Multiplex Assay Market Size, Share, and Growth Analysis, By Product Type (Consumables, Instruments), By Type (Protein Multiplex Assays, Nucleic Acid Multiplex Assays), By Technology, By Application, By End-User, By Region - Industry Forecast 2025-2032
상품코드 : 1673585
리서치사 : SkyQuest
발행일 : 2025년 03월
페이지 정보 : 영문 219 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,652,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,951,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,250,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

멀티플렉스 분석 시장 규모는 2023년 37억 달러, 2024년 40억 5,000만 달러에서 2032년에는 83억 7,000만 달러로 성장하고, 예측 기간(2025-2032년) 동안 9.5%의 연평균 복합 성장률(CAGR)을 보일 것으로 예상됩니다.

세계 멀티플렉스 분석 시장은 만성 질환 및 감염성 질환의 유병률 증가와 기존 방법 대비 멀티플렉스 분석의 장점으로 인해 크게 성장하고 있습니다. dMMR 고형암 식별을 위한 Roche와 같은 FDA 승인과 같은 동반 진단 약물의 사용이 증가하고 있으며, 이는 이 분야의 미래가 유망하다는 것을 증명합니다. 비소세포폐암과 같은 암의 생존율을 3배까지 높일 수 있는 조기 진단은 시장 확대 가능성을 더욱 강조하고 있습니다. 또한, 바이오마커 검증 및 자동화 시스템에 대한 수요가 증가하면서 하이스루풋 분석의 필요성이 높아지고 있습니다. 암, 자가면역질환, 신경퇴행성 질환 등 다양한 용도에 대응하는 멀티플렉스 어세이는 조기 발견과 인지도를 높이는데 매우 중요하며, 궁극적으로 시장 성장의 원동력이 될 것입니다.

목차

서론

조사 방법

주요 요약

시장 역학과 전망

주요 시장 인사이트

멀티플렉스 어세이 시장 규모 : 제품 유형별&CAGR(2025-2032년)

멀티플렉스 어세이 시장 규모 : 유형별&CAGR(2025-2032년)

멀티플렉스 어세이 시장 규모 : 기술별&CAGR(2025-2032년)

멀티플렉스 어세이 시장 규모 : 용도별&CAGR(2025-2032년)

멀티플렉스 어세이 시장 규모 : 최종사용자별&CAGR(2025-2032년)

멀티플렉스 어세이 시장 규모 : 지역별&CAGR(2025-2032년)

경쟁 정보

주요 기업 개요

결론과 제안

LSH
영문 목차

영문목차

Multiplex Assay Market size was valued at USD 3.7 billion in 2023 and is poised to grow from USD 4.05 billion in 2024 to USD 8.37 billion by 2032, growing at a CAGR of 9.5% during the forecast period (2025-2032).

The global multiplex assay market is experiencing significant growth driven by the increasing prevalence of chronic and infectious diseases and the advantages of multiplex assays over traditional methods. The rising utilization in companion diagnostics is particularly noteworthy, as evidenced by FDA approvals like Roche's for identifying dMMR solid tumors, indicating a promising future for this sector. Early disease diagnosis, which can triple survival rates for cancers such as non-small cell lung cancer, further emphasizes the market's expansion potential. Additionally, the validation of biomarkers and demand for automated systems bolster the need for high-throughput assays. With applications spanning cancer, autoimmune diseases, and neurodegenerative disorders, multiplex assays are pivotal in enhancing early detection and raising awareness, ultimately fueling market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Multiplex Assay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Multiplex Assay Market Segments Analysis

Global Multiplex Assay Market is segmented by Product Type, Type, Technology, Application, End-User and region. Based on Product Type, the market is segmented into Consumables, Instruments and Software. Based on Type, the market is segmented into Protein Multiplex Assays, Nucleic Acid Multiplex Assays and Cell-based Multiplex Assays. Based on Technology, the market is segmented into Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-time PCR and Others. Based on Application, the market is segmented into Research & Development and Clinical Diagnostics. Based on End-User, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Multiplex Assay Market

The increasing emphasis on personalized medicine is significantly fueling the growth of the multiplex assay market. These assays facilitate the simultaneous analysis of several biomarkers, which enhances patient stratification and leads to more tailored treatment options. By enabling healthcare providers to assess multiple health indicators at once, multiplex assays contribute to more accurate diagnoses and effective therapeutic strategies. This capability not only optimizes patient care but also supports the shift towards individualized therapies that cater to specific patient needs, thus reinforcing the demand for these advanced diagnostic tools in clinical settings.

Restraints in the Multiplex Assay Market

The multiplex assay market faces significant restraints primarily due to regulatory challenges that can hinder their widespread adoption. The complex nature of these assays necessitates obtaining regulatory approval, a process that is often time-consuming and financially burdensome. Such stringent requirements can deter manufacturers from developing and introducing new multiplex assays into the market, ultimately slowing innovation and limiting the availability of these advanced diagnostic tools. Consequently, the lengthy regulatory procedures may restrict market growth and access to potentially valuable multiplex assays that could significantly enhance diagnostic accuracy and efficiency across various medical applications.

Market Trends of the Multiplex Assay Market

The multiplex assay market is witnessing a significant trend towards the adoption of multiplex immunoassays, driven by their efficiency in measuring multiple protein targets within a single sample. This capability not only streamlines workflows but also enhances the accuracy and throughput of diagnostic testing, drug discovery, and biomarker identification processes. As healthcare continues to shift towards personalized medicine and more precise diagnostics, the demand for these assays is expected to grow steadily. Furthermore, advancements in technology that facilitate higher sensitivity and multiplexing capabilities are propelling market growth, positioning multiplex immunoassays as essential tools in clinical research and therapeutics.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Multiplex Assay Market Size by Product Type & CAGR (2025-2032)

Global Multiplex Assay Market Size by Type & CAGR (2025-2032)

Global Multiplex Assay Market Size by Technology & CAGR (2025-2032)

Global Multiplex Assay Market Size by Application & CAGR (2025-2032)

Global Multiplex Assay Market Size by End-User & CAGR (2025-2032)

Global Multiplex Assay Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기